Literature DB >> 11728616

Effect of electroconvulsive therapy on hematological parameters.

S Chaturvedi1, R K Chadda, U Rusia, N Jain.   

Abstract

Although a complete blood count is part of the evaluation before the use of electroconvulsive therapy (ECT), there are no known hematological contraindications for the procedure. A preliminary study was done on 31 randomly selected psychiatric patients (chronic schizophrenia, n=10; acute depression, n=8; acute mania, n=6; acute psychosis, n=6; delusional disorder, n=1) receiving ECT to study its hematological effects. Blood samples were drawn just before and 0, 1 and 2 h after ECT. Hemoglobin (Hb%), total and differential leukocyte count (TLC and DLC), red blood cell (RBC) count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and platelet count were measured on a fully automated hematology analyzer (Sysmex K-1000). Significant changes were found in TLC, percentage of polymorphs and lymphocytes, and Hb%. Changes in other parameters were not statistically significant. More such studies are needed to substantiate these observations and to understand the mechanism and implication of these effects.

Entities:  

Mesh:

Year:  2001        PMID: 11728616     DOI: 10.1016/s0165-1781(01)00303-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

Review 1.  Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine-Immune Therapeutic Mechanisms and Clinical Implications.

Authors:  Milagros Rojas; Daniela Ariza; Ángel Ortega; Manuel E Riaño-Garzón; Mervin Chávez-Castillo; José Luis Pérez; Lorena Cudris-Torres; María Judith Bautista; Oscar Medina-Ortiz; Joselyn Rojas-Quintero; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 2.  Electroconvulsive therapy in the medically ill.

Authors:  Eric J Christopher
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

3.  Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy.

Authors:  Masaki Nishiguchi; Hiroki Kikuyama; Tetsufumi Kanazawa; Atsushi Tsutsumi; Takao Kaneko; Hiroyuki Uenishi; Yasuo Kawabata; Seiya Kawashige; Jun Koh; Hiroshi Yoneda
Journal:  Psychiatry Investig       Date:  2015-04-20       Impact factor: 2.505

Review 4.  Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?

Authors:  E M van Buel; K Patas; M Peters; F J Bosker; U L M Eisel; H C Klein
Journal:  Transl Psychiatry       Date:  2015-07-28       Impact factor: 6.222

Review 5.  Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments.

Authors:  Elisabetta Maffioletti; Alessandra Minelli; Daniela Tardito; Massimo Gennarelli
Journal:  Genes (Basel)       Date:  2020-09-18       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.